Pharma Journalist -

DNAtrix, a clinical stage, biotechnology company developing virus-driven immunotherapies for cancer, announced the successful intratumoral administration of DNX-2401 with the Alcyone…
Read More...

PeptiDream has entered into a Technology License Agreement with US-based Genentech, a member of the Roche Group, to non exclusively license its Peptide Discovery Platform System (PDPS)…
Read More...

Medidata announced that it has signed a multi-year enterprise deal with Hanmi Pharmaceutical, one of South Korea's leading drug makers. A Medidata customer since 2013, the …
Read More...

Oracle announced that after a detailed review and selection process, Pfizer has selected Oracle Health Sciences InForm Cloud Service and the Oracle Siebel Clinical Trial Management and…
Read More...

An innovative virtual reality smartphone app – A Walk Through Dementia – will launch at a three-day public installation at St Pancras International Station from 2 June. The…
Read More...

Delivra has entered into a technology licensing agreement with Kalytera Therapeutics. Based in California, Kalytera is a pharmaceutical company developing a portfolio of…
Read More...

Integral Molecular has developed an ultra high-throughput microfluidic B-cell cloning technology that can interrogate tens of millions of immune cells (B-cells), enabling deep mining of…
Read More...

PaizaBio has secured an agreement with Taiwan-based JHL Biotech to provide fill-finish services for multiple JHL projects. New Mexico-based PaizaBio will provide these services to…
Read More...

Bayer and ERS signed a patent license agreement whereby Bayer gains access to ERS’ CRISPR-Cas9 genome-editing patents for certain cross-divisional applications in Bayer’s core strategic…
Read More...

As one of medicine’s largest challenges, viral infections often escape vaccines due to their natural ability to mutate rapidly and develop drug resistance easily. Many viruses, such as…
Read More...